Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics. [electronic resource]
Producer: 20110519Description: 1506-16 p. digitalISSN:- 1476-5462
- Animals
- Antigens, CD20 -- metabolism
- Antineoplastic Agents -- therapeutic use
- Cells, Cultured
- Chlorocebus aethiops
- Cyclophosphamide -- therapeutic use
- Humans
- Kaplan-Meier Estimate
- Lymphoma, Mantle-Cell -- drug therapy
- Measles virus -- genetics
- Mice
- Mice, SCID
- Molecular Targeted Therapy
- Oncolytic Viruses -- genetics
- Salvage Therapy
- Tumor Burden -- drug effects
- Vero Cells
- Vidarabine -- analogs & derivatives
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.